Drugs / JMKX005425
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07208136 | Oct 2025 → Dec 2027 expected | cancer | Jemincare | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JMKX005425 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07208136 ↗ |
| Route | Oral | “JMKX005425 administered orally.” NCT07208136 ↗ |